166 related articles for article (PubMed ID: 6823373)
41. Steroid receptor pattern of human colorectal neoplasms.
Bojar H; Heim ME; Petzinna D; Staib W
Anticancer Res; 1984; 4(3):129-32. PubMed ID: 6331798
[TBL] [Abstract][Full Text] [Related]
42. [Estrogen and progesterone receptors in human liver: does their study contribute to a better understanding of benign contraceptive-associated liver tumors?].
Pirovino M; Wälti E; Akovbiantz A; Arrenbrecht S; Zava D; Bühler H; Schmid M
Schweiz Med Wochenschr; 1986 Jul; 116(29):971-3. PubMed ID: 3020682
[TBL] [Abstract][Full Text] [Related]
43. Estrogen receptor expression is a common feature of ovarian borderline tumors.
Abu-Jawdeh GM; Jacobs TW; Niloff J; Cannistra SA
Gynecol Oncol; 1996 Feb; 60(2):301-7. PubMed ID: 8631556
[TBL] [Abstract][Full Text] [Related]
44. Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
Liu JF; Hirsch MS; Lee H; Matulonis UA
Gynecol Oncol; 2009 Dec; 115(3):401-6. PubMed ID: 19796795
[TBL] [Abstract][Full Text] [Related]
45. Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovary.
Jänne O; Kauppila A; Syrjälä P; Vihko R
Int J Cancer; 1980 Feb; 25(2):175-9. PubMed ID: 7390646
[TBL] [Abstract][Full Text] [Related]
46. Tamoxifen therapy for advanced ovarian cancer.
Schwartz PE; Keating G; MacLusky N; Naftolin F; Eisenfeld A
Obstet Gynecol; 1982 May; 59(5):583-8. PubMed ID: 7070729
[TBL] [Abstract][Full Text] [Related]
47. Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs.
Donnay I; Rauïs J; Devleeschouwer N; Wouters-Ballman P; Leclercq G; Verstegen J
Am J Vet Res; 1995 Sep; 56(9):1188-94. PubMed ID: 7486397
[TBL] [Abstract][Full Text] [Related]
48. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in normal and carcinomatous endometrium.
Neumannova M; Kauppila A; Vihko R
Obstet Gynecol; 1983 Feb; 61(2):181-8. PubMed ID: 6571973
[TBL] [Abstract][Full Text] [Related]
49. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.
De Sousa Damião R; Fujiyama Oshima CT; Stávale JN; Gonçalves WJ
Oncol Rep; 2007 Jul; 18(1):25-32. PubMed ID: 17549341
[TBL] [Abstract][Full Text] [Related]
50. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
Schulze MH; Buchmann J
Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188
[TBL] [Abstract][Full Text] [Related]
51. Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas.
Holt JA; Lyttle CR; Lorincz MA; Stern SD; Press MF; Herbst AL
J Natl Cancer Inst; 1981 Aug; 67(2):307-18. PubMed ID: 6943370
[TBL] [Abstract][Full Text] [Related]
52. [Relation between estrogen receptors and the clinical morphological characteristics of primary breast cancer].
Vishniakova VV; Ermilova VD; Murav'eva NI; Bassalyk LS
Arkh Patol; 1981; 43(7):20-3. PubMed ID: 7271502
[TBL] [Abstract][Full Text] [Related]
53. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A
Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452
[TBL] [Abstract][Full Text] [Related]
54. Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer.
Gamzatova Z; Villabona L; Dahlgren L; Dalianis T; Nillson B; Bergfeldt K; Masucci GV
Gynecol Oncol; 2006 Oct; 103(1):145-50. PubMed ID: 16542716
[TBL] [Abstract][Full Text] [Related]
55. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
Keshgegian AA
Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
[TBL] [Abstract][Full Text] [Related]
56. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
57. Estrogen and progesterone receptors in epithelial ovarian malignancies.
Sutton GP; Senior MB; Strauss JF; Mikuta JJ
Gynecol Oncol; 1986 Feb; 23(2):176-82. PubMed ID: 3943759
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical similarities between pancreatic mucinous cystic tumor and ovarian mucinous cystic tumor.
Suzuki Y; Sugiyama M; Abe N; Fujioka Y; Atomi Y
Pancreas; 2008 Jan; 36(1):e40-6. PubMed ID: 18192871
[TBL] [Abstract][Full Text] [Related]
59. Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors.
Farinola MA; Gown AM; Judson K; Ronnett BM; Barry TS; Movahedi-Lankarani S; Vang R
Int J Gynecol Pathol; 2007 Oct; 26(4):375-82. PubMed ID: 17885486
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
